Double C2-Like Domains, alpha (DOC2A) (N-Term) Peptide
DOC2A
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all DOC2A products
- DOC2A (Double C2-Like Domains, alpha (DOC2A))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SDYFPRGPGP EGGGGGGGEA PAHLVPLALA PPAALLGATT PEDGAEVDSY
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- DOC2A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DOC2A (Double C2-Like Domains, alpha (DOC2A))
- Background
-
There are at least two protein isoforms of the Double C2 protein, namely alpha (DOC2A) and beta (DOC2B), which contain two C2-like domains. DOC2A and DOC2B are encoded by different genes, these genes are at times confused with the unrelated DAB2 gene which was initially named DOC-2. DOC2A is mainly expressed in brain and is suggested to be involved in Ca(2+)-dependent neurotransmitter release. Alternative splicing results in multiple transcript variants.
Alias Symbols: Doc2
Protein Size: 400 - Gene ID
- 8448
- NCBI Accession
- NM_001282062, NP_001268991
- UniProt
- Q14183
-
You are here:
